Charles Weston
Stock Analyst at RBC Capital
(0.20)
# 4,556
Out of 4,698 analysts
351
Total ratings
38%
Success rate
-5.6%
Average return
Main Sectors:
Stocks Rated by Charles Weston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LON: OXB Oxford Biomedica plc | Reiterated: Buy | 900p | 447p | +101.34% | 31 | Sep 2, 2026 | |
| ETR: EVT Evotec SE | Maintained: Buy | €10.00 | €3.15 | +217.46% | 54 | Aug 13, 2026 | |
| ETR: SRT3 Sartorius Aktiengesellschaft | Maintained: Hold | €220.00 | €247.20 | -11.00% | 23 | Aug 12, 2026 | |
| EPA: DIM Sartorius Stedim Biotech S.A. | Maintained: Buy | €210.00 | €195.30 | +7.53% | 22 | Aug 12, 2026 | |
| BIT: 1SXP SCHOTT Pharma AG & Co. KGaA | Maintained: Buy | €21.00 | €23.00 | -8.70% | 9 | Aug 12, 2026 | |
| ETR: AFX Carl Zeiss Meditec AG | Maintained: Hold | €32.00 | €32.70 | -2.14% | 2 | Aug 6, 2026 | |
| LON: SN Smith & Nephew plc | Maintained: Hold | 1,350p → 1,250p | 1,070p | +16.82% | 2 | Aug 6, 2026 | |
| SWX: LONN Lonza Group AG | Maintained: Buy | CHF 760.00 | CHF 577.80 | +31.53% | 40 | Aug 3, 2026 | |
| LON: CTEC Convatec Group PLC | Maintained: Buy | 215p → 315p | 230p | +37.08% | 15 | Aug 2, 2026 | |
| SWX: BANB Bachem Holding AG | Maintained: Buy | CHF 110.00 | CHF 75.05 | +46.57% | 12 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | CHF 44.00 | CHF 44.00 | - | 9 | Jul 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,600p → 1,400p | 500p | +180.00% | 4 | Jun 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | 225p | 160p | +40.63% | 31 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | CHF 108.00 → CHF 96.00 | CHF 71.00 | +35.21% | 16 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 1,900p | 1,297p | +46.49% | 23 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 480p → 411p | 364p | +12.86% | 21 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $70.88 | - | 1 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $290 | $103.99 | n/a | 1 | Jan 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 310p | 237p | n/a | 20 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 26.00 | CHF 3.42 | n/a | 4 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | kr 287.00 | kr 42.78 | n/a | 2 | Apr 13, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | 160p | 70p | n/a | 1 | Nov 2, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7.07 | $0.7203 | n/a | 8 | Apr 24, 2018 |
Oxford Biomedica plc
Sep 2, 2026
Reiterated: Buy
Price Target: 900p
Current: 447p
Upside: +101.34%
Evotec SE
Aug 13, 2026
Maintained: Buy
Price Target: €10.00
Current: €3.15
Upside: +217.46%
Sartorius Aktiengesellschaft
Aug 12, 2026
Maintained: Hold
Price Target: €220.00
Current: €247.20
Upside: -11.00%
Sartorius Stedim Biotech S.A.
Aug 12, 2026
Maintained: Buy
Price Target: €210.00
Current: €195.30
Upside: +7.53%
SCHOTT Pharma AG & Co. KGaA
Aug 12, 2026
Maintained: Buy
Price Target: €21.00
Current: €23.00
Upside: -8.70%
Carl Zeiss Meditec AG
Aug 6, 2026
Maintained: Hold
Price Target: €32.00
Current: €32.70
Upside: -2.14%
Smith & Nephew plc
Aug 6, 2026
Maintained: Hold
Price Target: 1,350p → 1,250p
Current: 1,070p
Upside: +16.82%
Lonza Group AG
Aug 3, 2026
Maintained: Buy
Price Target: CHF 760.00
Current: CHF 577.80
Upside: +31.53%
Convatec Group PLC
Aug 2, 2026
Maintained: Buy
Price Target: 215p → 315p
Current: 230p
Upside: +37.08%
Bachem Holding AG
Jul 31, 2026
Maintained: Buy
Price Target: CHF 110.00
Current: CHF 75.05
Upside: +46.57%
Jul 7, 2026
Downgraded: Hold
Price Target: CHF 44.00
Current: CHF 44.00
Upside: -
Jun 15, 2026
Maintained: Buy
Price Target: 1,600p → 1,400p
Current: 500p
Upside: +180.00%
May 26, 2026
Reiterated: Buy
Price Target: 225p
Current: 160p
Upside: +40.63%
Mar 16, 2026
Maintained: Hold
Price Target: CHF 108.00 → CHF 96.00
Current: CHF 71.00
Upside: +35.21%
Mar 4, 2026
Maintained: Buy
Price Target: 1,900p
Current: 1,297p
Upside: +46.49%
Feb 24, 2026
Maintained: Buy
Price Target: 480p → 411p
Current: 364p
Upside: +12.86%
Feb 11, 2026
Upgraded: Buy
Price Target: n/a
Current: $70.88
Upside: -
Jan 7, 2025
Reiterated: Buy
Price Target: $290
Current: $103.99
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: 310p
Current: 237p
Upside: n/a
Jul 12, 2021
Maintained: Buy
Price Target: CHF 26.00
Current: CHF 3.42
Upside: n/a
Apr 13, 2021
Maintained: Buy
Price Target: kr 287.00
Current: kr 42.78
Upside: n/a
Nov 2, 2018
Maintained: Buy
Price Target: 160p
Current: 70p
Upside: n/a
Apr 24, 2018
Maintained: Buy
Price Target: $7.07
Current: $0.7203
Upside: n/a